Morforex
Non-marketed appetite suppressant drug
- None
- 4-[2-[(α-Methylphenethyl)amino]ethyl]morpholine
- 41152-17-4
- 3047774
- 2310095
- O9J6ITY8UX
- Interactive image
- CC(Cc1ccccc1)NCCN2CCOCC2
InChI
- InChI=1S/C15H24N2O/c1-14(13-15-5-3-2-4-6-15)16-7-8-17-9-11-18-12-10-17/h2-6,14,16H,7-13H2,1H3
- Key:ISEKMORYCCULAL-UHFFFAOYSA-N
Morforex (INN; Bo 637), also referable to as N-morpholinoethylamphetamine, is an anorectic which was never marketed.[1][2]
It produces amphetamine as an active metabolite.[3]
Synthesis
Amphetamine is reacted with N-Chloroethylmorpholine [3240-94-6] in the presence of IPA solvent.
See also
- Fenethylline
- Phenmetrazine
References
- ^ Ganellin CR, Triggle DJ (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. pp. 1377–. ISBN 978-0-412-46630-4.
- ^ World Health Organization (2000). International Nonproprietary Names (INN) for Pharmaceutical Substances. World Health Organization. ISBN 978-0-11-986227-0.
- ^ Goodwin BL (10 November 2004). Handbook of Biotransformations of Aromatic Compounds. CRC Press. pp. 13–. ISBN 978-0-203-64196-5.
- ^ FR 2199M, "N-morpholino-1 n-phénylisopropylamino-2 éthane [N-morpholino-1 N-phenylisopropylamino-2 ethane]", published 1963-12-09, assigned to Brevets Pharmaceutiques et Cosmetologiques
- v
- t
- e
Antiobesity agents/Anorectics (A08)
antagonists
glucagon agonists
receptor agonists
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e